Creative Edge Nutrition Analyst Report

Creative Edge Nutrition, Inc. (OTC: FITX) has a good thing going with supplements claiming to boost your health and muscle mass. But it now plans to add a marijuana-related division that could begin selling dried weed for medicinal uses by this summer. There's potential for great revenue for investors, but high risk.

Medical marijuana proponents will tell you that this organic substance is just what the doctor ordered. Research into its effects shows beneficial results, including pain reduction, appetite improvement, sleep enhancement and generally a better attitude.

But should bud also be considered a healthy supplement?

Creative Edge Nutrition seems to think so, and is developing a way to add marijuana products to its extensive lines of herbal supplements, powders and other products designed to enhance body and mind.

Last month, it announced that it has received approval to build what could be Canada’s largest legal production facility for dried marijuana for medicinal marijuana and marijuana seeds.

Work has supposedly begun although permits to actually sell the product for medicinal purposes are still forthcoming, a definite hitch in any multi-national marketing plan.

But that hasn’t stopped investors from getting behind FITX, which has seen a phenomenal increase in per-share value this year.

Financial analysts have been a little hesitant to make firm recommendations on any company in this sector – the risk is so high, track records are so short, and it’s hard to tell who is blowing smoke.

View this report for a closer look at FITX here: http://bit.ly/FITXAnalystReport

 

 

About StocksImpossible.com

 

StocksImpossible.com is the leading source for micro-cap and small-cap stock reports and analysis. We work closely with the very best Chartered Financial Analysts and financial writers in the industry to bring accurate and useful information to the investment community.

For the Stock Profiles Text Keyword "Profits" to 25827 to Receive Instant Mobile Alerts